Provides a single source for order and project management with customer access to historical submissions and reports
Alcami, a leading provider of custom development and manufacturing services for the pharmaceutical and biotechnology industries, is setting the industry standard for project management and transparency with its new Customer Portal and Mobile Application: Alcami OnDemand.
The initial phase will concentrate on the sample submission process within its Analytical Testing offering.
The new customer portal allows Alcami’s clients and prospects unprecedented and rapid access and visualisation into their ongoing projects.
The portal will serve as a single source for customer project and order management with shared views to manage orders, libraries of compounds, test results and accounting information.
“The new system addresses the unmet market need for a simplified sample submission process, real-time tracking of sample submissions and projects, customer access to historical data and transparency,” stated Chief Commercial Officer, Syed T. Husain.
“Alcami OnDemand is another exciting first-to-market initiative that allows us to provide a personalised customer experience to the pharma and biotech industry.”
Little-to-no training is required for users of Alcami OnDemand. The dashboard provides straightforward, intuitive controls that allow for quick and efficient completion of tasks. Customer information is pre-populated to reduce data entry requirements.
When necessary, the system also provides user prompts based on real-time project data. Customers will have access not only to historical order information and reporting data, but also snapshot views of the status of their projects with real-time updates. As a result, creating, submitting and tracking requests and accessing research data will now be a seamless experience.
The Customer Portal is currently undergoing beta testing for submission of samples by a selected group of existing analytical testing customers. Launch of the application to new customers will take place in June 2017.
Alcami plans to expand the application across its API and drug product manufacturing and development services platforms throughout 2017 and 2018. Further information will be provided while the beta programme is under way.